Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
For common, easily recognised ailments that are usually short-lived and cause few side effects in normal use
TIPS: 1
The trials reported minimal injection site issues, with no concerning patterns of local inflammation, infection, or tissue damage
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions
US$ 23.92
US$ 20.18
US$ 27.29
